Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897182 · ClinicalTrials.gov registry record
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 96
- Enrollment target
NCT00897182 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 96 participants.
The verdict
NCT00897182 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 96 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood and bone marrow in the laboratory from patients with cancer may help doctors learn more about changes that occur in DNA and identify genes related to cancer. It may also help doctors diagnose cancer and predict how patients will respond to treatment. PURPOSE: This research study is identifying cancer-related genes in blood and/or bone marrow samples from patients with acute myeloid leukemia.
Interventions
- GENETIC microarray analysis
- GENETIC polymerase chain reaction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2008-05 |
| Est. Completion | 2014-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00897182
The ClinicalTrials.gov registry entry for NCT00897182 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which microarray analysis is the first listed.
NCT00897182 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00897182 about?
NCT00897182 is a clinical study titled "Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia". RATIONALE: Studying samples of blood and bone marrow in the laboratory from patients with cancer may help doctors learn more about changes that occur in DNA and identify genes related to cancer. It may also help doctors diagnose cancer and predict how patients will respond to treatment. PURPOSE: Th...
What is the current status of trial NCT00897182?
This trial is currently completed. The enrollment target is 96 participants. The study started on 2008-05. Estimated completion is 2014-03.
What interventions are being tested in trial NCT00897182?
The interventions under investigation include: microarray analysis (GENETIC), polymerase chain reaction (GENETIC).
Who is sponsoring clinical trial NCT00897182?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.